Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Gynaecological Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18386465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

  2004cited by this paper
• Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.

  2003cited by this paper
• Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

  2002cited by this paper
• Clear-cell and papillary serous cancer: treatment options.

  2001cited by this paper
• The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

  2000cited by this paper
• Clear cell carcinoma of the endometrium: Prognosis and metastatic pattern

  1996cited by this paper
• Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

  1995cited by this paper
• Low‐Stage Clear‐Cell Carcinoma of the Endometrium

  1995cited by this paper
• Clear cell carcinoma of the endometrium

  1987cited by this paper
• Clear cell carcinoma of the endometrium

  1979cited by this paper
• Clear cell carcinoma of the endometrium: an uncommon entity with a favorable prognosis.

  1979cited by this paper
• Clear cell carcinoma of the endometrium: an analysis of 21 cases.

  1976cited by this paper

• Factors Predicting Type II Histology in Endometrial Biopsies Among Postmenopausal Minority Women at a Safety-Net Hospital

  2020cites this paper
• High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations

  2018cites this paper
• Uterine Papillary Serous Carcinoma—Still an Enigma?

  2017cites this paper
• Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer

  2016cites this paper
• A Retrospective Study of the Treatment Results & Patterns of Failure of Type II Endometrial Cancer Patients Treated at Radiotherapy Department, NCI, Cairo University during the Period from January 2000 till December 2012

  2016cites this paper
• Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy

  2016cites this paper
• Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes?

  2016cites this paper
• Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.

  2016cites this paper
• Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases

  2013cites this paper
• Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression

  2012cites this paper
• Tumor-stromal interactions in Type I and Type II endometrial cancer: The role of CXCL12/CXCR4 and HGF/c-Met/bFGF in a large cohort of endometrial cancer patients

  2011influential citation
• Factors associated with Type I and Type II endometrial cancer

  2010cites this paper
• Cancer de l'endomètre de stade I

  2008cites this paper
• [Stage I endometrial carcinoma].

  2008cites this paper